In a week in which the US FDA moved to restrict emergency use authorisations for new Covid-19 vaccines, developers will be heartened to see that the agency’s willingness to greenlight coronavirus treatments remains undiminished.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,